OpenAlex
PricingAboutJobs
Log inGet started
Work

Prospective evaluation of serial 2-hydroxyglutarate in acute myeloid leukemia (AML) to determine response to therapy and predict relapse.

HTML

Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2012.30.15_suppl.6606
Authors: Amir Tahmasb Fathi, Omar Ibrahim Abdel-Wahab, Hossein Sadrzadeh, Julia Foster, Meghan Burke, Darrell R. Borger, A. John Iafrate, Sophia Adamia, Suiyang Liu, Karen K. Ballen, Philip C. Amrein, Eyal C. Attar, Kimberly Straley, Katharine Yen, David P. Schenkein, Donna S. Neuberg, Ross L. Levine, Yi-Bin Albert Chen, Richard M. Stone
Institutions: Harvard University, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Agios Pharmaceuticals (United States)
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2997996235
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms